Mice lacking the IL-22 receptor on a high fat diet are prone to develop metabolic syndrome and administration of IL-22 in obese mouse models reversed several symptoms such as hyperglycemia and insulin resistance (242, 243). Here, IL22 is linked to metabolic syndrome.